NCT02372240: A trial that was reported late by Vivolux AB
This trial has reported, although it was 2322 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02372240 |
|---|---|
| Title | VLX1570 and Low-Dose Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma: A Clinical and Correlative Phase 1/2 Study |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 8, 2015 |
| Completion date | May 24, 2017 |
| Required reporting date | May 24, 2018, midnight |
| Actual reporting date | Oct. 1, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 2322 |